APA (7th ed.) Citation

M, T., F, Y., J, S., X, S., Y, W., & J, S. (2025). Targeting SPATS2 in lung adenocarcinoma: Implications for prognosis and immune-based therapy. Discover oncology, 16(1), 1504. https://doi.org/10.1007/s12672-025-03179-7

Chicago Style (17th ed.) Citation

M, Teng, Yan F, Shang J, Sun X, Wang Y, and Shen J. "Targeting SPATS2 in Lung Adenocarcinoma: Implications for Prognosis and Immune-based Therapy." Discover Oncology 16, no. 1 (2025): 1504. https://doi.org/10.1007/s12672-025-03179-7.

MLA (9th ed.) Citation

M, Teng, et al. "Targeting SPATS2 in Lung Adenocarcinoma: Implications for Prognosis and Immune-based Therapy." Discover Oncology, vol. 16, no. 1, 2025, p. 1504, https://doi.org/10.1007/s12672-025-03179-7.